Back to Trades
Santos da Silva Jorge
Chief Executive OfficerDirectorCIK 0001920509
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 1
- Active
- 2025–2026
Santos da Silva Jorge, Chief Executive Officer, Director, has filed 4 SEC reports (2025–2026), all concentrated in MoonLake Immunotherapeutics (MLTX), totaling $8.7M in disclosed volume. Weighing $0 bought versus $8.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 13 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge | Chief Executive Officer, Director | Sell | $2.0M |
| Jul 2 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge | Chief Executive Officer, Director | Sell | $956.9K |
| Apr 14 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge | Chief Executive Officer, Director | Sell | $2.8M |
| Dec 10 | MLTX MoonLake Immunotherapeutics | Santos da Silva Jorge | Chief Executive Officer, Director | Sell | $3.0M |
4 filings